Pharmaceutical Decisions in Response to Epidemics: A Case Study

As an epidemic spreads through a fictitious country in the developing world, various stakeholders debate the responsibility of a drug company with the patent on a life-saving treatment. This video presentation, from the Ethics Center Conference, "The Future of Pharmaceuticals," was held Oct. 3, 2003.

Portraying parties from NGO representative to pharmaceutical company CEO are:

• Bob Armitage, vice president and general patent counsel, Eli Lilly & Co.

• Sarah Bachman, visiting scholar, Markkula Center for Applied Ethics

• Michael Meyer, professor, Department of Philosophy, SCU

• Vernellia Randall, professor, University of Dayton School of Law

• J. Leighton Reid, partner, Alloy Ventures, co-founder Affimax

• Moderator, Kirk O. Hanson. executive director, Markkula Center for Applied Ethics

Read a text version of this case